Headland Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$218K Buy
+182
New +$186K 0.05% 58
2026
Q1
– Sell
-220
Closed -$236K – 68
2025
Q4
$236K Buy
+220
New +$210K 0.07% 59
2025
Q1
– Sell
-296
Closed -$228K – 65
2024
Q4
$228K Buy
+296
New +$245K 0.08% 48

Other funds holding LLY

Headland Capital's LLY Position: Q2 2026 in Review

Headland Capital opened a new position in Eli Lilly (LLY) in Q2 2026: 182 shares worth $218K. The stake represents 0.05% of the portfolio and ranks #58 among its holdings. This is a return to the name: Headland Capital previously reported a position in LLY as recently as Q4 2025.

Headland Capital first reported a position in LLY in Q4 2024 and has held it in 3 quarters since. The position peaked at $236K in Q4 2025. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Headland Capital held 182 shares of Eli Lilly worth $218K as of Q2 2026.
  • Eli Lilly was a new Headland Capital position in Q2 2026.
  • Eli Lilly made up 0.05% of Headland Capital's portfolio in Q2 2026, its #58 holding.
  • Headland Capital first reported a position in Eli Lilly in Q4 2024 and has held it in 3 quarters since.
  • Headland Capital's Eli Lilly position peaked at $236K in Q4 2025.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Headland Capital's 13F filing for Q2 2026, filed 29 Jul 2026.